DOCSLIB.ORG

Unlocking Value Creating Three World-Leading Companies 2017 Annual Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

UNLOCKING VALUE CREATING THREE WORLD-LEADING COMPANIES 2017 ANNUAL REPORT AGRICULTURE MATERIALS SCIENCE SPECIALTY PRODUCTS WorldReginfo - b6146b17-9ab6-4688-a070-21c5404fe6dd FINANCIAL HIGHLIGHTS In millions, except amounts per share 2017 2016 YoY Net sales $62,484 $48,158 $14,326 Pro forma net sales1 $79,535 $70,894 $8,641 Income from continuing operations, net of tax $1,669 $4,404 $(2,735) Pro forma operating EBITDA1, 2 $16,166 $14,114 $2,052 Earnings per common share from continuing operations – diluted $0.95 $3.52 $(2.57) Pro forma adjusted earnings per common share from continuing operations – diluted 1, 3 $3.40 $2.79 $0.61 All year-over-year comparisons are on a pro forma basis and exclude significant items. 1 Pro forma information was prepared in accordance with Article 11 of Regulation S-X. 2 Pro forma Operating EBITDA is defined as earnings (i.e., “Pro forma income from continuing operations before income taxes”) before interest, depreciation, amortization and foreign exchange gains (losses), excluding the impact of significant items. 3 Pro forma adjusted earnings per share is defined as “Pro forma earnings per common share from continuing operations – diluted” excluding the after-tax impact of pro forma significant items and the after-tax impact of pro forma amortization expense associated with DuPont’s intangible assets. WorldReginfo - b6146b17-9ab6-4688-a070-21c5404fe6dd Dear DowDuPont Shareholders, In 2017, we took significant steps forward to create Strengthening our Foundation new value for you, our fellow shareholders. First and Immediately following the DowDuPont transaction foremost, we closed the historic merger of Dow close, our Board and management, with input and DuPont, with a clear purpose to combine our from a range of stakeholders and outside advisors, highly complementary portfolios and create three completed a thorough review of the portfolios industry-leading growth companies in Agriculture, of each of the three intended companies. Materials Science, and Specialty Products. The outcome was unanimous approval of targeted adjustments between the Materials Science and Specialty Products divisions. Together, these moves, which account for more than $8 billion in sales and approximately $2.4 billion in operating EBITDA, further secure each intended company’s industry-leading position and better equip both to deliver greater value-added solutions and to capitalize on enhanced growth opportunities. We are on track to launch these three world-class companies, with Materials Science separating by the end of the first quarter of 2019, followed shortly after by Agriculture and Specialty Products, by June 1, 2019. Andrew N. Liveris Edward D. Breen Capturing Value & Growth Synergies By year-end, the portfolios for these intended new A critical element of the integration work underway is companies were well aligned, with our teams moving delivering on our cost synergies commitment. By the quickly to integrate, begin capturing synergies and end of 2017, we had already achieved annual run- prepare for the spins. Importantly, we also continued rate savings of more than $800 million – exceeding to report strong results after becoming a merged our commitment of $500 million of run-rate savings. entity – building on solid performance from both Based on this quick value capture, we recently legacy organizations and demonstrating our team’s increased our cost synergy commitment from ability to focus on customers as we also prepare $3 billion to $3.3 billion. At the same time, we see the for the future. opportunity to capture $1 billion in growth synergies – a prime focus for our teams. As the intended Having achieved this important progress, we are companies grow with highly focused strategies in now firmly focused on developing three growth their respective industries, we expect each will be a businesses. Through the merger and intended vibrant contributor to all of its communities, given the separations, we are enabling these businesses to growth profiles we are creating for each business. allocate capital more effectively, apply powerful innovation capabilities that are more focused and more productive and expand value-added products and solutions to more customers worldwide. With lower cost structures, increased agility and distinctive investment profiles, each will be better positioned to grow and to thrive over the long term, as they reinvest in science and innovation to deliver significant value for shareholders. 1 WorldReginfo - b6146b17-9ab6-4688-a070-21c5404fe6dd 2017 Performance Highlights A Bright Future Ahead • In Agriculture, new product growth enabled the Our confidence in the future comes, in large measure, division to deliver a solid year despite several from the energy and passion of our people, coupled market headwinds. Innovative products including with the shared values of our respective heritage ARYLEX™ herbicide, LEPTRA® corn hybrids, companies. These guideposts will enable us to VESSARYA™ fungicide and ISOCLAST™ insecticide continue to anticipate and quickly adapt to change continued to generate growth. We also launched and maintain our leadership positions – connecting ENLIST™ cotton in the U.S., and received import science to the marketplace and creating new approval from China to enable the full launch of opportunities to help our customers solve the ENLIST™ corn in the U.S. and Canada for the 2018 world’s challenges. growing season. Looking ahead, we expect our robust pipeline to launch 10 new seed products As we look ahead, we remain focused on capitalizing and 11 new crop protection products over on the synergies, and in particular on the significant the next five years. growth opportunities in front of us. And we look forward to positioning and launching three growth • Materials Science delivered top- and bottom-line companies that will deliver long-term rewards growth on robust consumer-led demand in core for our shareholders. end markets where our segments hold leadership positions today. The division also continued to Thank you for your investment in DowDuPont. advance its long-term growth projects – most notably on the U.S. Gulf Coast, with the startup of its new world-scale ethylene, polyethylene and elastomers facilities, as well as with its Sadara joint venture in the Middle East, which achieved Andrew N. Liveris Edward D. Breen full commercial operations for all 26 production Executive Chairman Chief Executive Officer units, with additional value-added products across these key chains and others including isocyanates, propylene oxide/propylene glycol, polyols, amines and glycol ethers. In addition, the innovation engine in Materials Science delivered more than 2,500 new products in our target markets and won numerous awards. • Specialty Products also produced strong top- and bottom-line growth on continued demand in key end markets. Our Electronics & Imaging business delivered strong results through the semiconductor and consumer electronics end markets, Transportation & Advanced Polymers experienced robust demand from the automotive market and broad-based demand from electronics and industrial markets, and the Nutrition & Biosciences businesses performed well in the microbial control solutions, probiotics and biomaterials end markets. In addition, we closed our acquisition of FMC’s Health and Nutrition business, which significantly enhances this portfolio by expanding our offerings and bringing access to the fast-growing pharmaceuticals excipients market. 2 WorldReginfo - b6146b17-9ab6-4688-a070-21c5404fe6dd AGRICULTURE: A Global Innovation Leader Agriculture Sales The Agriculture Division brings together the strengths of DuPont Pioneer, DuPont Crop Protection and Dow AgroSciences to form a pure-play Agriculture Company with the industry’s most comprehensive and balanced portfolio, focused resources, and the scale needed to deliver the innovative solutions its customers need. The highly productive innovation engine and combined robust pipeline of solutions across seed, crop protection, seed-applied technologies, and digital agriculture will n Seed enable the intended Agriculture Company to bring a broader suite of products to the n Crop Protection market faster and be an even better partner to farmers around the world, helping 2017 Pro Forma them to increase their productivity and profitability. Sales: $14,342 MM • Global leader in production • Superior solutions, greater choice • Strong advocate for farmers 2017 Pro Forma Op. EBITDA: agriculture with a presence in over and deeply committed to being a • World-class R&D capabilities support $2,611 MM 130 countries innovation and new technologies strong corporate citizen LEADING PORTFOLIO OF PRODUCTS AND SERVICES WITH ENHANCED R&D ENGINE TO DRIVE FUTURE GROWTH DELIVERING SOLUTIONS FOR GROWERS ACROSS SEED AND CROP PROTECTION CATEGORIES • Cereals Herbicides Alfalfa Cotton Soybeans • Corn and Soybean Herbicides • Fungicides Canola Rice Sunflowers • Insecticides • Pasture and Land Management Cereals Silage Inoculants Wheat • Rice, Trees and Vines Herbicides • Seed-Applied Technologies Corn Sorghum Digital Ag • Specialty Crop Herbicides • Structural Pest Management • Turf and Ornamental Pest Management NEW PRODUCT PORTFOLIO AND PIPELINE 2017 - 2018 2018 - 2019 Beyond CROP PROTECTION • Arylex™ Active • Inatreq™ Active • Fungicides 1-5 • Enlist Duo® herbicide with Colex-D® • Pyraxalt™ insect control® • Herbicides 1-2 • Expanded Zorvec™ Launch in AP and LA • Rinskor™ Active • Insecticides 1-5 • Lumisena™ seed treatment • Zorvec™ expansion in EMEA
Recommended publications
  • DUPONT DATA BOOK SCIENCE-BASED SOLUTIONS Dupont Investor Relations Contents 1 Dupont Overview

    DUPONT DATA BOOK SCIENCE-BASED SOLUTIONS Dupont Investor Relations Contents 1 Dupont Overview

    DUPONT DATA BOOK SCIENCE-BASED SOLUTIONS DuPont Investor Relations Contents 1 DuPont Overview 2 Corporate Financial Data Consolidated Income Statements Greg Friedman Tim Johnson Jennifer Driscoll Consolidated Balance Sheets Vice President Director Director Consolidated Statements of Cash Flows (302) 999-5504 (515) 535-2177 (302) 999-5510 6 DuPont Science & Technology 8 Business Segments Agriculture Electronics & Communications Industrial Biosciences Nutrition & Health Performance Materials Ann Giancristoforo Pat Esham Manager Specialist Safety & Protection (302) 999-5511 (302) 999-5513 20 Corporate Financial Data Segment Information The DuPont Data Book has been prepared to assist financial analysts, portfolio managers and others in Selected Additional Data understanding and evaluating the company. This book presents graphics, tabular and other statistical data about the consolidated company and its business segments. Inside Back Cover Forward-Looking Statements Board of Directors and This Data Book contains forward-looking statements which may be identified by their use of words like “plans,” “expects,” “will,” “believes,” “intends,” “estimates,” “anticipates” or other words of similar meaning. All DuPont Senior Leadership statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control.
  • 2017 Sustainability Report 2 2017 Sustainability Report 3

    2017 Sustainability Report 2 2017 Sustainability Report 3

    2017 SUSTAINABILITY REPORT 2 2017 SUSTAINABILITY REPORT 3 We’re living today in a rapidly changing world. Globalization and technology are accelerating the pace of change, and a growing population is putting more TABLE O F pressure on our planet’s resources. Through science and collaboration, Dow’s people are working across the Company to redefine the role of business by innovating solutions that advance business and society and by valuing nature in all of our decisions. With our 2025 Sustainability Goals, Dow is focused on CONTENTS Redefining the Role of Business in Society developing collaborative blueprints that integrate public policy solutions, science and technology, and value chain innovation. The aim is to build solutions between government, business and society that generate shared value and are long lasting, scalable and transformative. These 10-year goals are designed to harness Dow’s innovation strengths, global reach and the passion of our employees. WHO WE ARE WHY WE DO IT WHAT WE DO HOW WE DO IT INTRODUCTION ADDITIONAL GRI PROFILE GLOBAL OUR PRODUCTS OPERATIONS & INFORMATION CONTENT INDEX & PEOPLE CHALLENGES & OUR & SOLUTIONS PERFORMANCE COMMITMENTS The Dow Chemical Company dow.com/sustainability 4 2017 SUSTAINABILITY REPORT 5 ABOUT THE DOWDUPONT MERGER TRANSACTION AND INTENDED BUSINESS SEPARATIONS GRI 102-10 Dow (“the Company”) has been committed to transparently reporting our progress For the 15th year, Dow has applied the framework provided by the Global Reporting on sustainability for many years. This report reflects the Company’s performance for Initiative (GRI) to its annual sustainability report. GRI 102-52 This report has been Effective August 31, 2017, The Dow Chemical Company (“Dow”) and E.
  • Dow-Dupont-Filed-S4-3-1-2016

    Dow-Dupont-Filed-S4-3-1-2016

    As filed with the Securities and Exchange Commission on March 1, 2016 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DOWDUPONT INC. (Exact name of registrant as specified in its charter) Delaware 2821 81-1224539 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification No.) c/o The Dow Chemical Company c/o E. I. du Pont de Nemours and Company 2030 Dow Center 974 Centre Road Midland, MI 48674 Wilmington, DE 19805 (989) 636-1000 (302) 774-1000 (Name, address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Howard Ungerleider Nicholas Fanandakis DowDuPont Inc. DowDuPont Inc. c/o The Dow Chemical Company c/o E. I. du Pont de Nemours and Company 2030 Dow Center 974 Centre Road Midland, MI 48674 Wilmington, DE 19805 (989) 636-1000 (302) 774-1000 (Name, address, including zip code, and telephone number, including area code, of agents for service) Copies to: Charles J. Kalil, Esq. Stacy L. Fox, Esq. Michael J. Aiello, Esq. Peter Allan Atkins, Esq. The Dow Chemical Company E. I. du Pont de Nemours and James R. Griffin, Esq. Brandon Van Dyke, Esq. 2030 Dow Center Company Sachin Kohli, Esq. Skadden, Arps, Slate, Meagher Midland, MI 48674 974 Centre Road Weil, Gotshal & Manges LLP & Flom LLP (989) 636-1000 Wilmington, DE 19805 767 Fifth Avenue Four Times Square (302) 774-1000 New York, NY 10153 New York, NY 10036 (212) 310-8000 (212) 735-3000 Approximate date of commencement of the proposed sale of the securities to the public: As soon as practicable after this Registration Statement becomes effective and upon completion of the mergers described in the enclosed document.

  • Corteva, Inc. (Exact Name of Registrant As Specified in Its Charter)

    As filed with the U.S. Securities and Exchange Commission on May 6, 2019 File No. 001-38710 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Corteva, Inc. (Exact name of registrant as specified in its charter) Delaware 82-4979096 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 974 Centre Road Wilmington, Delaware 19805 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: 302-774-1000 Securities to be registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which to be so registered each class is to be registered Common Stock, par value $0.01 per share New York Stock Exchange Securities to be registered pursuant to Section 12(g) of the Act: None Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☐ Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
  • DOWDUPONT INC. (Exact Name of Registrant As Specified in Its Charter)

    DOWDUPONT INC. (Exact Name of Registrant As Specified in Its Charter)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (Date of earliest event reported): August 31, 2017 DOWDUPONT INC. (Exact name of registrant as specified in its charter) Delaware 81-1224539 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) c/o The Dow Chemical Company c/o E. I. du Pont de Nemours and Company 2030 Dow Center 974 Centre Road Midland, MI 48674 Wilmington, DE 19805 (Address of principal executive offices)(Zip Code) (989) 636-1000 (302) 774-1000 (Registrant’s telephone numbers, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
  • Corteva, Inc. (Exact Name of Registrant As Specified in Its Charter)

    Corteva, Inc. (Exact Name of Registrant As Specified in Its Charter)

    As filed with the U.S. Securities and Exchange Commission on May 6, 2019 File No. 001-38710 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 4 TO FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Corteva, Inc. (Exact name of registrant as specified in its charter) Delaware 82-4979096 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 974 Centre Road Wilmington, Delaware 19805 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: 302-774-1000 Securities to be registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which to be so registered each class is to be registered Common Stock, par value $0.01 per share New York Stock Exchange Securities to be registered pursuant to Section 12(g) of the Act: None Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ‘ Accelerated filer ‘ Non-accelerated filer È Smaller reporting company ‘ Emerging growth company ‘ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
  • Dowdupont 2018 10-K

    Dowdupont 2018 10-K

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to ________ Commission file number: 001-38196 DOWDUPONT INC. (Exact name of registrant as specified in its charter) Delaware 81-1224539 State or other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) c/o The Dow Chemical Company c/o E. I. du Pont de Nemours and Company 2211 H.H. Dow Way, Midland, MI 48674 974 Centre Road, Wilmington, DE 19805 (989) 636-1000 (302) 774-1000 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, par value $0.01 per share New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
  • Annual Report 2020

    Annual Report 2020

    KEEP GROWING. ANNUAL REPORT 2020 CORTEVA ANNUAL REPORT 2020 ACCELERATING VALUE CREATION Corteva delivered strong performance in our first full year as a standalone pure-play agriculture company despite the effects of an unprecedented year. We leveraged the power of our multi-channel, multi-brand distribution, superior product pipeline, and unmatched customer relationships to deliver above-market organic1 sales growth while taking actions across the organization to expand our margins and increase operating efficiency. At the same time, we maintained our focus on disciplined capital allocation, balancing our investment in ongoing growth initiatives with enhancing the return of capital to our shareholders. We are confident that the actions we took over the course of 2020 position us well to substantially accelerate our earnings growth in the coming year and over the long term. We invite you to read more about how Corteva continues to increase value for our shareholders, customers and society—living up to our purpose as a global agriculture industry leader, enriching the lives of producers and consumers now and for generations CONTENTS to come. FINANCIAL HIGHLIGHTS ................................................1 LETTER TO SHAREHOLDERS .......................................2 2020 HIGHLIGHTS ........................................................... 5 CORPORATE GOVERNANCE STRUCTURE SUPPORTS LONG-TERM VALUE CREATION .......6 IN IT FOR GOOD: SHAPING THE FUTURE OF AGRICULTURE THROUGH ENVIRONMENTAL SUSTAINABILITY ........................7 BOLDLY
  • 2013 DATA BOOK Dupont Investor Relations Contents 1 Dupont Overview

    2013 DATA BOOK Dupont Investor Relations Contents 1 Dupont Overview

    Growth Commitment Results Impact Partners 2013 DATA BOOK DuPont Investor Relations Contents 1 DuPont Overview 2 Corporate Financial Data Consolidated Income Statements Carl Lukach Tim Johnson Randy Stone Consolidated Balance Sheets Vice President Director Director (302) 774-0001 (515) 535-2177 (302) 774-9810 Consolidated Statements of Cash Flows Selected Additional Data 6 DuPont Science & Technology 8 Business Segments Agriculture Electronics & Communications Industrial Biosciences Amy Trojanowski Patricia Esham Director Specialist Nutrition & Health (302) 774-2297 (302) 774-9870 Performance Materials Safety & Protection Performance Chemicals The DuPont DATA BOOK has been prepared to assist financial analysts, portfolio managers and others in understanding and evaluating the company. This book presents graphics, tabular and other 22 Corporate Financial Data statistical data about the consolidated company and its business segments. Segment Information Forward-Looking Statements This DATA BOOK contains forward-looking statements which may be identified by their use of Selected Additional Data words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “estimates” or other words of similar meaning. Although they reflect our current expectations, these statements are not Inside Back Cover guarantees of future performance, but involve a number of risks, uncertainties, and assumptions. Some of which include: fluctuations in energy and raw material prices; failure to develop and market Board of Directors and new products and
  • Printmgr File

    Printmgr File

    2019 ANNUAL MEETING AND PROXY STATEMENT NOTICE OF THE ANNUAL MEETING OF STOCKHOLDERS Dear Stockholder: At the 2019 Annual Meeting of Stockholders (the “2019 Meeting”), stockholders will vote on the following matters either by proxy or in person: Date: Agenda: Tuesday, June 25, 2019 1. Election of the 12 Directors named in the Proxy Statement. Time: 2. Advisory resolution to approve executive compensation. 8:00 A.M. Eastern Time 3. Ratification of the appointment of PricewaterhouseCoopers LLP as Location: the Company’s independent registered public accounting firm for 2019. 974 Centre Road Chestnut Run Plaza, Building 730 4–7. Stockholder proposals. Wilmington, Delaware 19805 8. Transaction of any other business as may properly come before the 2019 Meeting. How to Vote Your vote is important. Whether or not you plan on attending the 2019 Meeting, please vote your shares as soon as possible by internet, telephone or mail. BY INTERNET BY PHONE BY MAIL www.proxyvote.com 1-800-690-6903 or the Use the postage-paid number provided on your envelope provided voting instructions The Board of Directors of DowDuPont Inc. (the “Board”) has set the close of business on April 26, 2019, as the record date for determining stockholders who are entitled to receive notice of the 2019 Meeting and to vote. As permitted by U.S. Securities and Exchange Commission (the “SEC”) rules, proxy materials were made available via the internet. Notice regarding availability of proxy materials and instructions on how to access those materials were mailed to certain stockholders of record on or about April 29, 2019 (the “Notice”).
  • 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

    1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

    Case 3:19-cv-03857-SK Document 1 Filed 07/03/19 Page 1 of 68 1 ELIZABETH HOPKINS, SBN: 324431 KANTOR & KANTOR 2 19839 Nordhoff Street Northridge, California 91324 3 Telephone: (818) 886-2525 4 Facsimile: (818) 350-6274 Email: [email protected] 5 W. DANIEL MILES, III (pro hac vice pending) 6 JAMES EUBANK (pro hac vice pending) BEASLEY ALLEN CROW METHVIN 7 PORTIS & MILES, P.C. 8 218 Commerce Street Montgomery, Alabama 36104 9 Telephone: (800) 898-2034 Facsimile: (334) 965-7555 10 Email: [email protected] 11 [email protected] 12 THOMAS O. SINCLAIR (pro hac vice pending) REBECCA D. GILLILAND (pro hac vice pending) 13 SINCLAIR LAW FIRM, LLC 2000 SouthBridge Parkway, Suite 601 14 Birmingham, Alabama 35209 15 Telephone: (877) 249-0091 Facsimile: (205) 868-0894 16 Email: [email protected] [email protected] 17 EDWARD S. STONE (pro hac vice pending) 18 EDWARD STONE LAW P.C. 19 175 West Putnam Avenue, 2nd Floor Greenwich, Connecticut 06830 20 Telephone: (203) 930-3401 Facsimile: (203) 348-8477 21 Email: [email protected] 22 ATTORNEYS FOR PLAINTIFFS AND 23 THE PROPOSED CLASS 24 25 26 27 28 CLASS ACTION COMPLAINT - 1 - Case 3:19-cv-03857-SK Document 1 Filed 07/03/19 Page 2 of 68 1 UNITED STATES DISTRICT COURT 2 NORTHERN DISTRICT OF CALIFORNIA 3 KRISHNAN R. THONDUKOLAM, STEPHEN ) Case No.: 4 W. RECORDS, WILLIAM C. MALLONEE and ) 5 DAVID L. EVERETT, individually and as ) representatives on behalf of a class of similarly ) 6 situated persons, ) CLASS ACTION COMPLAINT ) FOR VIOLATIONS OF ERISA 7 Plaintiffs, ) 8 ) vs.